🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Li Di

Pfizer (United States)

ORCID: 0000-0001-6117-9022

Also affiliated with Recursion (United States)

Pharmacology, Toxicology and PharmaceuticsMedicineComputer ScienceChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 5 papers. Top paper: Systematic Evaluation of Bioorthogonal Reactions in Live Cells with Clickable HaloTag Ligands: Implications for Intracellular Imaging.

191 citations

Joshua C. Judkins, Christopher W. am Ende, T. Eric Ballard, Yinzhi Fang, Keith Riccardi +6 more

Advantages of Good Drug-like Properties

Drug-like Properties: Concepts, Structure Design and Methods(2008)10.1016/b978-012369520-8.50003-6
N/A
0.442DataRank · unranked
18 citations

Li Di, Edward H. Kerns

N/A
0.241DataRank · unranked
4 citations

Edward H. Kerns, Li Di

9 citations

Li Di, Shelley Shen, Yuying Zhao, Ann M. Neumeyer, Duygu Selcen +3 more

11 citations

Lin Lei, Shengyao Su, Shu Zhang, Nairong Xie, Ling Li +7 more